Evidence map›Paper›PMID 28445979›Full record

ArticleOncotarget2017

The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.

Chengxian Guo, Yuling Huang, Jingjing Yu, Lijuan Liu, Xiaochang Gong, Min Huang, Chunling Jiang, Yulu Liao, Lihua Huang, Guoping Yang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The psychological status in patients with nasopharyngeal carcinoma during radiotherapy.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Association between NF-BioMed research international · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Impact ofIn vivo (Athens, Greece)
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Chengxian GuoCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Yuling HuangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Jingjing YuCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Lijuan LiuDepartment of Pharmacy, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Xiaochang GongDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Min HuangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Chunling JiangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Yulu LiaoDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Lihua HuangCenter for Medical Experiments, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Guoping YangCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Jingao LiDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, China.
Jiangxi Provincial Cancer Hospital · CNThird Xiangya Hospital · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is one of the primary choices for the treatment of nasopharyngeal carcinoma (NPC) and may result in severe radiotoxicities on normal tissues. Single nucleotide polymorphisms (SNPs) in genes of cell cycle and NF-κB pathways have been linked with the prognoses of various cancers. The aim of this study was to explore whether SNPs of genes involved in cell cycle and NF-κB pathways are associated with responses to radiotherapy in NPC patients. We selected 3 SNPs in cell cycle pathway and 5 SNPs in NF-κB pathway and genotyped them in 154 NPC patients treated with radiotherapy. Multivariate logistic regression was used to determine the association of these 8 SNPs with the responses to radiotherapy. We observed that cyclin-dependent kinase inhibitor gene CDKN2A rs3088440 was significantly related with a poorer treatment efficacy on the primary tumor and cervical lymph node after radiotherapy, and also with a decreased risk of grade 3-4 acute radiation-induced myelosuppression. In some subgroups, cyclin D1 gene CCND1 rs9344 and inhibitor of κB kinase gene IKBKB rs12676482 were related with the grade 3-4 acute radiation-induced myelosuppression, and CCND1 rs9344 was also associated with grade 3-4 acute radiation-induced oral mucositis. The current results reveal that SNPs in genes of cell cycle pathwayand NF-κB pathway have the potential to predict the clinical responses to radiotherapy for NPC patients.

Indexed as

AdolescentAdultAgedAged, 80 and overCarcinomaCell CycleFemaleGenotypeHumansMaleMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsNF-kappa BPolymorphism, Single NucleotideYoung AdultNF-kappa Bcell cycleclinical responsesnasopharyngeal carcinoma (NPC)NF-κB pathwaysingle nucleotide polymorphism (SNP)

Identifiers

PMID28445979
PMCPMC5421934
OpenAlexW2593097430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.